Using mixed co‐cultures of EGFR− and EGFR+ tumor cells (not in ECM) with activated T‐cells, CD3xEGFR bsAbs have been shown to effectively trigger bystander killing when the proportion of EGFR− tumor cells was up to 70% [22]. Here, EGFR is linked to neoplasm.